Breast diseases histologically diagnosed at a tertiary facility in Uganda (2005

Breast diseases histologically diagnosed at a tertiary facility in Uganda (2005–2014)

Published:2018-12 Issue:1 Volume:18 Page:
ISSN:1471-2407
Container-title:BMC Cancer
language:en
Short-container-title:BMC Cancer

Author:

Ssemmanda Salvatore^ORCID,Katagirya Eric,Bukirwa Phiona,Alele David,Lukande Robert,Kalungi Samuel

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Genetics,Oncology

Link

http://link.springer.com/content/pdf/10.1186/s12885-018-5208-6.pdf

Reference36 articles.

1. WHO |Breast cancer: prevention and control WHO, 2016.

2. Ferlay J, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015;136(5):E359–86.

3. Sitas F, Parkin M, Chirenje Z, Stein L, Mqoqi N, Wabinga H. The International Bank for Reconstruction and Development / The World Bank. Cancers. 2006;1:293–294.

4. Sangma MBM, Panda K, Dasiah S. A clinico-pathological study on benign breast diseases. J Clin Diagn Res. 2013;7(3):503–6.

5. WHO| Global cancer rates could increase by 50% to 15 million by 2020, WHO 2010.

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Histopathological Profile of Different Breast Lesions: A Single-Center Observational Study;Cureus;2024-05-16

2. Mapping Evidence on the Burden of Breast, Cervical, and Prostate Cancers in Sub-Saharan Africa: A Scoping Review;Frontiers in Public Health;2022-06-16

3. An audit of patients clinically deemed as high risk for malignant breast pathology at the Helen Joseph Hospital Breast Clinic;South African Journal of Surgery;2021

4. The spectrum of male breast disease at Charlotte Maxeke Johannesburg Academic Hospital - a 3-year retrospective review;South African Journal of Surgery;2021

5. Novel HLA-A2 restricted antigenic peptide derivatives with high affinity for the treatment of breast cancer expressing NY-ESO-1;Bioorganic Chemistry;2020-10